APA (7th ed.) Citation

HA, E., I, R., NM, S., MN, A., ST, A., SM, E., & GS, H. (2026). Corrigendum to "Design, synthesis, and antitumor activity of PLGA nanoparticles incorporating a discovered benzimidazole derivative as EZH2 inhibitor" [Chem.-Biol. Interact. 344 (2021) 109530]. Chemico-biological interactions, 429, 111959. https://doi.org/10.1016/j.cbi.2026.111959

Chicago Style (17th ed.) Citation

HA, Elkot, Ragab I, Saleh NM, Amin MN, Al-Rashood ST, El-Messery SM, and Hassan GS. "Corrigendum to "Design, Synthesis, and Antitumor Activity of PLGA Nanoparticles Incorporating a Discovered Benzimidazole Derivative as EZH2 Inhibitor" [Chem.-Biol. Interact. 344 (2021) 109530]." Chemico-biological Interactions 429 (2026): 111959. https://doi.org/10.1016/j.cbi.2026.111959.

MLA (9th ed.) Citation

HA, Elkot, et al. "Corrigendum to "Design, Synthesis, and Antitumor Activity of PLGA Nanoparticles Incorporating a Discovered Benzimidazole Derivative as EZH2 Inhibitor" [Chem.-Biol. Interact. 344 (2021) 109530]." Chemico-biological Interactions, vol. 429, 2026, p. 111959, https://doi.org/10.1016/j.cbi.2026.111959.